Company news

Sareum Holdings plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Preliminary Results for Year Ended 30 June 2026

November 2, 2026

Notice of Results and Investor Presentation

October 30, 2026

Results of WRAP Offer

October 28, 2026

Early Close of WRAP Retail Offer

October 27, 2026

Capital Access Window - Sareum Holdings Plc

October 26, 2026

WRAP Retail Offer for up to £100,000

October 26, 2026

Fundraise, Retail Offer and AIM Restoration

October 26, 2026

Capital Access Window - Sareum Holdings Plc

October 8, 2026

Capital Access Window

October 8, 2026

Completion of Dosing in Toxicology Programme

July 20, 2026

Publication of Phase 1 data on SDC-1801 in BJCP

June 22, 2026

Half-Year Report for Six Months Ended 31 Dec 2025

March 12, 2026

Restart of Phase 2-enabling toxicology programme

February 17, 2026

Results of AGM

December 9, 2025

Annual General Meeting Statement

December 9, 2025

Notice of AGM, Annual Report and Accounts

November 17, 2025

Appointment of Joint Corporate Broker

October 30, 2025

Preliminary Results for Year Ended 30 June 2025

October 23, 2025

Update on toxicology study for SDC-1801

October 10, 2025

Notice of Results and Investor Presentation

October 7, 2025

Exercise of Warrants

September 26, 2025

Sareum Collaboration with Receptor.AI

August 12, 2025

Appointment of Sole Broker

July 4, 2025

Initiation of Toxicology Studies for SDC-1801

May 29, 2025

Update on TYK2/JAK1 and SRA737 Programmes

April 28, 2025

Director’s Dealing

March 27, 2025

Half-yearly Results to Dec 2024

March 26, 2025

Sareum Half-Year Report

March 25, 2025

Notice of HY Results and Investor Presentation

March 20, 2025

Institutional Equity Fundraise

March 13, 2025

Sareum Acquires Licence for SRA737

March 13, 2025

Update on SRA737

December 31, 2024

AGM Statement

December 19, 2024

Appointment of Joint Broker

December 18, 2024

Holding(s) in Company

December 17, 2024

Award of Share Options

December 16, 2024

Notice of AGM 2024

November 26, 2024

Annual Report 2023/24

November 26, 2024

Final Results for the Year Ended 30 June 2024

October 29, 2024

Notice of Final Results and Investor Presentation

October 23, 2024

Further Subscription to raise £1,000,000

October 21, 2024

Subscription to raise £2,364,000

October 11, 2024

Patent Allowance in China

September 16, 2024

US patent allowance

September 2, 2024

Management Changes

July 10, 2024

Positive Data from SDC-1801 Phase 1 Clinical Trial

July 1, 2024

Half-yearly Results to Dec 2023

April 29, 2024

Final Issue of RiverFort Subscription Shares

April 23, 2024

Issue of RiverFort Subscription Shares

April 19, 2024

Completion of Equity Fundraise

April 4, 2024

Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.